Priceless GEMMs: genetically engineered mouse models for colorectal cancer drug development

Jatin Roper1, Kenneth E Hung

  • 1Gastroenterology Division, Department of Medicine, Tufts Medical Center, Boston, MA 02111, USA.

Summary

Preclinical mouse models, including xenografts and genetically engineered mouse models (GEMMs), are vital for effective colorectal cancer (CRC) drug development. Newer GEMMs and advanced imaging enhance in vivo tumor assessment for translational research.